Caris Life Sciences director Jon Halbert reports purchase of 68,000 common shares worth $990,080

• Caris Life Sciences director Jon Halbert reported an indirect purchase of 68,000 common shares at a weighted average USD 14.56.
• Holdings at LAH Investments rose to 704,598 shares.
• Halbert also reported 118,621 shares held directly, with 637,887 shares held indirectly through a family trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001189394-26-000005), on July 13, 2026, and is solely responsible for the information contained therein.